loader

Park Medi World IPO 2025: All You Need to Know Before You Apply

park medi world ipo details
Piyush Prajapati 6 December, 2025

The Indian IPO market is in the limelight again, and this time, the focus is on a name from the healthcare sector: Park Medi World. As the company prepares to go public, investors in both retail and institutional spectrums continue to watch closely. Here's a comprehensive breakdown-from IPO structure and company profile to what the funds will be used for.

About Park Medi World

Park Medi World operates under the Park brand and is the second largest private hospital chain in North India as of March 2025. In bed capacity, the company is estimated to have about 3,000 beds, which is the highest in India according to a report.

The Park Medi World hospital network includes 14 NABH accredited super-speciality hospitals. The hospital offers more than 30 different super-specialities and specialties, including internal medicine, neurology, urology, gastroenterology, general surgery, orthopaedics, oncology, and more.

As of March 2025, Park Medi World's total bed capacity increased from 2,550 to 3,250 beds between March 2023 and September 2025. This shows that the company has a very aggressive growth strategy and continues to expand its services and reach.

Additionally, Park Medi World has an active expansion strategy with several new hospital projects planned for locations including Ambala, Panchkula, Rohtak, New Delhi, Gorakhpur and Kanpur.

Key IPO Details

Particulars Details
IPO Opening Date 10th December 2025
IPO Closing Date 12th December 2025
Issue Size Rs.920 Crores
Price Band Rs.154 to Rs.162
Lot Size 92 Shares
Listing at BSE, NSE
Registrar Kfin Technologies Limited
Allotment Date 15th December 2025
Initiation of Refunds 16th December 2025
Credit of Shares to Demat 16th December 2025
Listing Date 17th December 2025
Why Investors Are Watching Park Medi World IPO
  • Strong geographical footprint & capacity: Already, Park Medi World has a strong base in place with 14 hospitals across multiple states, namely Haryana, Delhi, Punjab, and Rajasthan, along with 3,000-plus beds.
  • Aggressive expansion pipeline: Plans to set up new hospitals in various regions could lead to expansion-driven growth and better reach.
  • Use of funds sounds prudent: Part of the IPO proceeds would go to debt repayment, which could improve financial health. The remainder would be used to fuel expansion and equipment upgrade.
  • Healthcare demand tailwinds: Considering the rise in healthcare needs in India, a network like that of Park Medi World—specializing in multi-specialty services—could substantially benefit from increased demand and may be regarded as a long-term play.

Who Should Consider Applying

Park Medi's world-wide IPO may be appropriate for those interested in:

  • Investing long-term in India's health care and health-related infrastructure.
  • Believing in growth potential of the private hospital industry primarily being in Tier 2 and Tier 3 centres.
  • The length of investment (2-5 years) is of medium-term duration allowing time for company expansion.
  • Moderately risk-tolerant when it comes to business operations and implementation challenges in the healthcare realm.
How to Apply for Park Medi World IPO

Investors can apply to Park Medi World IPO through:

  • Step 1: Go to the Equity IPO tab.
  • Step 2: Look for the Park Medi World IPO form and click on “ invest now “.
  • Step 3: Enter your PAN and click on the "Apply Now" button.
  • Step 4: Choose the scheme you want and enter the investment amount.
  • Step 5: Click on the "Continue" button to proceed.
Conclusion

The IPO of Park Medi World brings a well-established hospital chain to public markets, underpinned by aggressive expansion plans and a clear roadmap for debt reduction and infrastructure growth. To investors who can look beyond quick gains, this is arguably a foundational play on India's rising healthcare sector.

Piyush Prajapati 6 December, 2025

RR Investors Capital Services Pvt. Ltd AMFI-registered Mutual Fund Distributor

ARN-0032 Validity 14-Mar-2027

Head Office - 4th floor, Indraprakash Building 21, Barakhamba Road, New Delhi – 110001

callLandline Number
+91 11-4444-1111

Customer Care
+91 9350316010

Security
Follow Us

SEBI Registration No: NSE Cash: INB231219636 | SEBI Registration No: NSE Derivative: INF231219636 | SEBI Registration No: BSE Cash: INB011219632 | SEBI Registration No: MCX-SX: INE261219636 | SEBI Registration No: NSE Currency: INE231219636 | SEBI Registration No: USE: INE271219631 | SEBI Registration No: CDSL: IN-DP-CDSL-3242005 | NCDEX Membership No: 00635 | MCX Membership No: 28850 | NSEL Membership No: 10650 | RBI Registration No: NBFC: N-14.03215 | IRDA Registration Number : CB-066/03 | AMFI Registration No : ARN -0032| SEBI Registration No: Merchant Banker: INM000007508


* Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing.


© 2022 RR Investors Capital Services Pvt. Ltd | All Rights Reserved.